Related Experiment Video
Updated: Jun 15, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
A transition model for ordinal response data with random dropout: an application to the fluvoxamine data
Z Rezaei Ghahroodi1, M Ganjali, D Berridge
1Department of Statistics, Shahid Beheshti University, Tehran, Iran.
Abstract:
Many methods are available to analyze incomplete longitudinal ordinal responses. In this paper a general transition model is proposed for longitudinal ordinal responses with random dropout. Maximum likelihood estimates are obtained for the transition probabilities when there are repeated observations. The likelihood function of the general model is partitioned to make possible the use of existing software to estimate model parameters. Some reduced forms of the model are also considered where for estimation of parameters in these models one has to use numerical optimization methods. The approach is applied to the well-known Fluvoxamine data. For these data, two important results, which have not been previously reported, are obtained: (1) some transition probabilities are estimated to be zero and (2) the model for current response, which conditions on previous response, removes the effects of some covariates that had previously been significant.
Related Concept Videos
Censoring Survival Data
Dose Response Curve: Conventional Versus Nonmonotonic
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
Friedman Two-way Analysis of Variance by Ranks
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model